Founding Story
Established in 2018 by seasoned entrepreneurs and investors to nurture promising biotech startups.
Core Mission
Identifying, investing in, and developing the most promising biotech startups in Switzerland and Europe.
Unique Approach
Rigorous screening process to identify startups with the most promising technologies and strong teams.
Cutting-Edge Technologies
Providing access to state-of-the-art facilities and technologies to accelerate product development.
Strategic Partnerships
Leveraging a vast network to connect portfolio companies with strategic partners and investors.
Comprehensive Resources
We will continue to provide access to funding, mentorship, drug development support, legal and regulatory guidance, access to industry experts and investors and office, laboratory, and manufacturing space.
Innovative Portfolio
We aim to expand our biotech portfolio to autoimmune disorders, neurodegenerative diseases, and rare genetic disorders on top of oncology and infectious diseases.
Continued Support
With a strong network of investors and partners, Swiss Rockets AG is well positioned to continue supporting the most promising biotech startups and driving scientific innovation for improved patient outcomes.
